Reaction Details |
| Report a problem with these data |
Target | Muscarinic acetylcholine receptor M2 |
---|
Ligand | BDBM50103773 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_139759 (CHEMBL748895) |
---|
Ki | 0.51±n/a nM |
---|
Citation | Wang, Y; Chackalamannil, S; Hu, Z; Greenlee, WJ; Clader, J; Boyle, CD; Kaminski, JJ; Billard, W; Binch, H; Crosby, G; Ruperto, V; Duffy, RA; Cohen-Williams, M; Coffin, VL; Cox, KA; Grotz, DE; Lachowicz, JE Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists. J Med Chem45:5415-8 (2002) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Muscarinic acetylcholine receptor M2 |
---|
Name: | Muscarinic acetylcholine receptor M2 |
Synonyms: | ACM2_HUMAN | CHRM2 | Cholinergic, muscarinic M2 | Muscarinic acetylcholine receptor M2 and M4 | Muscarinic acetylcholine receptor M2 and M5 | RecName: Full=Muscarinic acetylcholine receptor M2 |
Type: | GPCR |
Mol. Mass.: | 51730.61 |
Organism: | Homo sapiens (Human) |
Description: | P08172 |
Residue: | 466 |
Sequence: | MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNY
FLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFD
RYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQF
FSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRI
VKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDE
ITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNI
VARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNT
VWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
|
|
|
BDBM50103773 |
---|
n/a |
---|
Name | BDBM50103773 |
Synonyms: | (4-Fluoro-naphthalen-1-yl)-(4-{2-[4-(4-methoxy-benzenesulfonyl)-phenyl]-[1,3]dioxolan-2-yl}-[1,4']bipiperidinyl-1'-yl)-methanone | CHEMBL74141 |
Type | Small organic molecule |
Emp. Form. | C37H39FN2O6S |
Mol. Mass. | 658.779 |
SMILES | COc1ccc(cc1)S(=O)(=O)c1ccc(cc1)C1(OCCO1)C1CCN(CC1)C1CCN(CC1)C(=O)c1ccc(F)c2ccccc12 |
Structure |
|